October 2007

advertisement
CHINESE MEDICINAL BIOTECHNOLOGY
Bimonthly
Established in December 2006
Responsible Institution
Ministry of Health of the People’s
Republic of China
Volume 2, Number 5
October 10, 2007
CONTENTS OF SELECTED ARTICLES
Sponsor
China Medicinal Biotech Association
Editorials
Revival of biomedical capital ………………………………………………… 321
7B Zaojunmiao Road, Haidian District,
Beijing 100081, China
Non-invasive imaging diagnosis of carotid plaque ………………………… 324
Editing
Editorial
Board
of
Medicinal Biotechnology
ZHANG Shi-yuan
ZHANG Wan-shi
Chinese
Tel: 0086-10-62135779
Fax: 0086-10-62115976
Email: cmbj01@126.com
http://www.cmbp.net.cn
Editor-in-Chief
ZHAO Kai(赵铠)
Managing Director
YAN Ming(燕鸣)
Original Articles
Application of laser capture microdissection and microarray
on analysis of differential gene expression in cancer …………………… 329
ZHANG Yun-fei, ZHANG Hua, ZHANG Bao-qun, WANG Hai-tao, CHEN Chao
Effect of Forskolin on the expression and distribution
of aquaporin8 in human WISH cells ……………………………………… 336
LU Wei, QI Hong-bo, HUANG Jin
Effect of human cellular genomic DNA on the HBV DNA in the culture
medium detected by real-time fluorescence quantitative PCR ………… 341
PAN Xiao-ben, HAN Jin-chao, ZHU Lin, GAO Yan, WEI Lai
Publishing
China Medicinal Biotech Association
Expression of scFv-lidamycin fusion protein
in Streptomyces globisporus C-1027 ……………………………………… 346
7B Zaojunmiao Road, Haidian District,
Beijing 100081, China
Tel: 0086-10-62135779
Fax: 0086-10-62115976
Email: cmba@cmba.org.cn
Quantitative determination of combining ratio of complete antigen
for chloramphenicol …………………………………………………………… 351
Printing
Beijing Zhongke Printing Limited
Company
Mail-Order
Editorial Department of Chinese
Medicinal Biotechnology
7B Zaojunmiao Road, Haidian District,
Beijing 100081, China
Tel: 0086-10-62135779
Fax: 0086-10-62115976
Email: cmbj01@126.com
CSSN
ISSN 1673-713X
CN 11- 5512 / R
Copyright© 2007 by the China
Medicinal Biotech Association
All articles published represent the
opinions of the authors, not reflecting
the official policy of the China
Medicinal Biotech Association or the
Editorial Board of Chinese Medicinal
Biotechnology, unless this is clearly
specified.
LI Bao-wei, HU Yun-feng, WANG Li-fei, CUI Zhi-hui, HONG Bin, SHAO Rong-guang
WANG Wen-jia, DONG Bin, TIAN Su-juan, YUAN Yin, HUANG Shu-lin
Study on the uptake of 99Tcm-DTPA-DG by tumor cells
after chemotherapy …………………………………………………………… 355
LIANG Jie, CHEN Yue, HUANG Zhan-wen, HE Ling, ZHAO Yan-ling
In vivo study of bone formation of PDLLA/HA composite ……………… 360
LI Jian-hua, SHAN Xue-zhi, LI Shi-pu
Study on ion-exchange membrane chromatography for purification
of recombinant hepatitis B virus surface antigen ………………………… 365
YAO Wei, DUAN Li-juan, ZHANG Yan-rui, ZHANG Ying, REN Ya-ping, CUI Tie-min
Reviews
Progress in the mechanism of targeting of nanoparticles ………………… 370
ZHAO Jun-xian, ZHANG Ying-ge
Advancement in the research on target antigens in anti-glomerular
basement membrane disease ………………………………………………… 373
YANG Rui, ZHAO Ming-hui
Advancement in the research on molecular
diagnosis of lymphoma ……………………………………………………… 376
BI Rui, LÜ Ning
Progress in the stability of structure of polypeptide drugs ………………… 380
GAO De-min, LIU Jin-feng, WANG Feng-shan
Development on the physiological functions of soybean isoflavones
and its separation and detection …………………………………………… 383
HAO Qing-nan, MA Chao, MA Bing-gang
Studies on structure-activity relationship of endomorphins ……………… 387
GAO Yan-feng, ZHAI Ming-xia
C-Jun N-terminal kinase and insulin resistance …………………………… 391
GUO Hong-hui, LING Wen-hua
Download